Looking to partner for targeted alpha therapy
development?


Our locations

Sydney

Level 7, Macquarie House, 167 Macquarie Street, Sydney, NSW, 2000, Australia

Newcastle

Lab 186, ATC Building Callaghan Campus, University of Newcastle, University Drive, Callaghan NSW 2308 Australia

Brisbane

Y-Block, Queensland Centre for Advanced Technologies (QCAT), 1 Technology Court, Pullenvale, QLD 4069, Australia

Adelaide

B78 Prescott Laboratories, The Braggs Building, The University of Adelaide, Adelaide, SA, 5005


Get in touch

By sending us a message, you agree to our friendly privacy policy.


Partnership Programs

AdvanCell operates a comprehensive partnership program for taking novel radioligand therapies from the lab through to Phase 1 and beyond.

cGMP Isotope

AdvanCell provides its cGMP isotope to partners removing reliance on external supply chains.

CMC

AdvanCell’s in-house manufacturing team and infrastructure ensures CMC development to meet FDA requirements.

Clinical Trials

AdvanCell has deep experience in running clinical trials for radioligand therapies.

Australian Advantage

Australia’s world-leading Nuclear Medicine expertise and infrastructure offers a smooth and competitive path for clinical development.